Cardiologist @ Mayo Clinic

Joined April 2020
Excited to present 3 abstracts at #AHA2022. Please stop by if you are interested. Looking forward to meeting and chatting with colleagues. Thanks to my supportive mentor Dr. @LermanAmir. @MayoClinicCV @MayoMrfa @AHAMeetings
2
3
20
#VPM2022 is tomorrow! Join course organiser @LermanAmir from 8:20 AM, who will be joined by @rkhamis @DrAdamHartley @GreggWStone @DavidErlinge and more! View the latest programme: millbrook-medical-conference… Register here: millbrook-medical-conference… @imperialcollege @ImperialNHLI
Congratulations on your first faculty meeting, way to go!
1
1
Amir Lerman retweeted
Many months of preparations are done! Counting the days for the Mayo Clinic Sheba cardiovascular symposium. Can't wait to meet everyone whose coming. The two day meeting will be followed by the @SHEBA_ innovation week ARC summit. #CardioTwitter @MayoClinicCV @drpaulfriedman
1
1
17
lerman and schaff myocardial bridging - Google Scholar scholar.google.com/scholar?q…
3
Amir Lerman retweeted
Elevated plasma ceramides are associated with early coronary atherosclerosis. @valentinardi @NadiaAkhiyatMD @LermanAmir #AHAJournals ahajournals.org/doi/10.1161/…
#MachineLearning aids clinical decision making in patients presenting with angina and non-obstructive coronary artery disease academic.oup.com/ehjdh/advan… #EHJDigital #cardiotwitter @BruiningNico @rafavidalperez @pauldub67
Carotid Plaques From Symptomatic Patients Are Characterized by Local Increase in Xanthine Oxidase Expression #stroke ow.ly/9Xoj50F8shn
14
35
Special thanks to @Michel_CorbanMD for his tireless efforts to make this happen, looking forward for future collaboration
Device treatment for microvascular angina and low CFR? Coronary sinus reducers implanted in the cath lab as inaugural cases of phase 2 open label study @rajivxgulati @adnanalkhouli @MayoClinicCV @drpaulfriedman
3
1
20
Device treatment for microvascular angina and low CFR? Coronary sinus reducers implanted in the cath lab as inaugural cases of phase 2 open label study @rajivxgulati @adnanalkhouli @MayoClinicCV @drpaulfriedman
8
28
7
111
Elad, great interview and promising technology for remote medicine
1
1
9